Lipoprotein composition and serum apolipoproteins in normoglycaemic first-degree relatives of non-insulin dependent diabetic patients

Atherosclerosis

Volumn 139, Issue 1, 1998, Pages 115-121

  Stewart, M W ^a   Humphriss, D B ^a   Mitcheson, J ^a   Webster, J ^a   Walker, M ^a   Laker, M F ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Apolipoprotein A I; Apolipoprotein B; Lipids; Lipoprotein composition; Non insulin dependent diabetes mellitus; Normoglycaemia; Relatives

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN; MALE;

EID: 0032127737     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00065-3     Document Type: Article

References (44)

1. Panzram G. Mortality and survival in Type 2 (non-insulin dependent) diabetes mellitus. Diabetologia. 30:1987;123-131.
2. Garcia M.J., McNamara P.M., Gordon T., Kannel W.B. Morbidity and mortality in diabetics in the Framingham population. 16 year follow up study. Diabetes. 23:1974;105-111.
3. Albrink M.J., Lavietes P.H., Man E.B. Vascular disease and serum lipids in diabetes mellitus. Ann Intern Med. 58:1963;305-323.
4. Howard B.V. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 28:1987;613-628.
5. Fontbonne A., Eschwege E., Cambien F., Richard J.-L., Ducimetiere P., Thibult N., Warnet J-M, Claude J-R, Rosselin G-Eet al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11 year follow up of the Paris prospective study. Diabetologia. 32:1989;300-304.
6. Jarrett RJ, Keen H. Diabetes and atherosclerosis. In: Keen H, Jarrett RJ, editors. Complications of Diabetes. London: Arnold, 1975:179-204.
7. Austin M.A., Breslow J.L., Hennekens C.H., Buring J.E., Willett W.C., Krauss R.M. Low-density lipoprotein subclass patterns and risk of myocardial infarction. Am J Hum Genet. 43:1988;838-846.
8. Tilly-Kiesi M., Syvanne M., Kuusi T., Lahdenpera S., Taskinen M.-R. Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease. J Lipid Res. 33:1992;333-342.
9. Stewart M.W., Laker M.F., Dyer R.G., Game F., Mitcheson J., Winocour P.H., Alberti K.G.M.M. Lipoprotein compositional abnormalities and insulin resistance in type 2 diabetic patients with mild hyperlipidemia. Arterioscler Thromb. 13:1993;1046-1052.
10. Reaven G.M., Chen Y.-D.I., Jeppesen J., Maheux P., Krauss R.M. Insulin resistance and hyperinsulinemia in individuals with small, dense, low-density lipoprotein particles. J Clin Invest. 92:1993;141-146.
11. James R.W., Pometta D. The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, Type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 34:1991;246-252.
12. Joven J., Vilella C.B., Turner P.R., Richart C., Masana L. Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin dependent diabetes mellitus. Clin Chem. 35:1989;813-816.
13. Kobberling J., Tillil H., Lorenz H.J. Genetics of type 2A and type 2B diabetes mellitus. Diabetes Res Clin Pract. 11:1985;311.
14. Eriksson J., Franssila-Kallunki A., Ekstrand A., Saloranta C., Widen E, Schalin C., Groop L. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. New Engl J Med. 321:1989;337-343.
15. Leslie R.D., Volkmann H.P., Poncher M., Hanning I., Orskov H. Alberti KGMM. Metabolic abnormalities in children of non-insulin dependent diabetics. Br Med J. 293:1986;840-842.
16. Warram J., Martin B., Soeldner J.S. Diminished insulin sensitivity in normoglycemic offspring of two non-insulin dependent diabetic parents. Diabetes. 37(Suppl 1):1988;9A.
17. Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.D., Patterson J.K., Ferranini E. Parental history of diabetes is associated with increased cardiovascular risk factors. Arteriosclerosis. 9:1989;928-933.
18. Haffner S.M., Stern M.P., Hazuda H.P., Mitchell B.M., Patterson J.K. Cardiovascular risk factors in confirmed prediabetic individuals. J Am Med Assoc. 263:1990;2893-2898.
19. Schumacher M.C., Maxwell T.M., Wu L.L., Hunt S.C., Williams R.R., Elbein S.C. Dyslipidemias among normoglycemic members of familial NIDDM pedigrees. Diabetes Care. 15:1992;1285-1289.
20. Stewart M.W., Webster J.M., Humphriss D., Berish T., Walker M., Laker M.F. Lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in normoglycaemic relatives of Type 2 diabetic patients. Atherosclerosis. 124:1996;119-124.
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
22. Schumaker V.N., Puppione D.L. Sequential flotation ultracentrifugation. Methods Enzymol. 128:1986;155-170.
23. Markwell M.A.K., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 87:1978;206-210.
24. Egusa G., Brady D., Grundy S., Howard B. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B. J Lipid Res. 24:1983;1261-1267.
25. Dormans T.P.J., Swinkels D.W., de Graaf J., Hendriks J.C.M., Stalenhoef A.F.H., Demacker P.N.M. Single-spin density-gradient ultracentifugation vs gradient gel electrophoresis: two methods for detecting low-density-lipoprotein heterogeneity compared. Clin Chem. 37:1991;853-858.
26. Sarlund H., Pyörälä K., Penttilä I., Laakso M. Early abnormalities in coronary heart disease risk factors in relatives of subjects with non-insulin-dependent diabetes. Arterioscler Thromb. 12:1992;657-663.
27. Laws A., Stefanick M.L., Reaven G.M. Insulin resistance and hypertriglyceridemia in non diabetic relatives of patients with non insulin dependent diabetes mellitus. J Clin Endocrinol Metab. 69:1989;343-347.
28. Groop L., Forsblom C., Lehtovirta M., Tuomi T., Karanko S., Nissén M., Ehrnström B-O, Fórsen B, Isomaa B, Snickers B, Taskinen M-Ret al. Metabolic consequences of a family history of NIDDM (The Botnia Study). Diabetes. 45:1996;1585-1593.
29. Perseghin G., Ghosh S., Gerow K., Sgulman G.I. Metabolic defects in lean nondiabetic offspring of NIDDM parents. Diabetes. 46:1997;1001-1009.
30. Reaven G.M., Lerner R.L., Stern M.P., Farquhar J.W. Role of insulin in endogenous hypertriglyceridemia. J Clin Invest. 46:1967;1756-1767.
31. Ferrannini E., Haffner S.M., Mitchell B.D., Stern M.P. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 34:1991;416-422.
32. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
33. Stewart M.W., Humphriss D.B., Berrish T.S., Barriocanal L.A., Trajano L.R., Alberti K.G.M.M., Walker M. Features of syndrome X in first degree relatives of NIDDM patients. Diabetes Care. 18:1995;1020-1022.
34. Barakat H.A., Carpenter J.W., Mclendon V.D., Khazanie P., Leggett N., Heath J., Marks R. Influence of obesity, impaired glucose tolerance and NIDDM on LDL structure and composition. Diabetes. 39:1990;1527-1533.
35. Avogaro P., Bittolo Bon G., Cazzolato G., Qunici G.B. Are apolipoproteins better predictors than lipids for atherosclerosis? Lancet. i:1979;901-903.
36. Sniderman A.D., Shapiro S., Marpole D., Skinner B., Teng B., Kwiterovich P.O. Association of coronary atherosclerosis with hyperbetalipoproteinaemia (increased protein but normal cholesterol levels in human plasma low density (b) lipoproteins). Proc Natl Acad Sci USA. 77:1980;604-608.
37. Riesen W.F., Mordasini R., Salzmann C., Theler A., Gurtner H.P. Apoproteins and lipids as discriminators of severity of coronary heart disease. Atherosclerosis. 37:1980;157-162.
38. Brunzell J.D., Sniderman A.D., Albers J.J., Kwiterovich P.O. Apoprotein B and AI and coronary heart disease in humans. Arteriosclerosis. 4:1984;79-83.
39. Durrington P.N., Hunt L., Ishola M., Kane J., Stephens W.P. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction. Br Heart J. 56:1986;206-212.
40. Durrington P.N., Ishola M., Hunt L., Arrol S., Bhatnagar D. Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease. Lancet. i:1988;1070-1073.
41. Craig W.Y., Palomaki G.E., Johnson A.M., Haddow J.E. Cigarette smoking-associated changes in blood lipid and lipoprotein concentrations: an analysis of published data. Br Med J. 298:1989;784-788.
42. Peeples L.H., Carpenter J.W., Israel R.G., Barakat H.A. Alterations in low-density lipoproteins in subjects with abdominal obesity. Metabolism. 38:1989;1029-1036.
43. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 137:1993;959-965.
44. Winocour P.H., Kaluvya S., Ramaiya K., Brown L., Millar J.P., Farrer M., Neil H.A.W., Laker M.F., Alberti K.G.M.M. The relationship between insulinemia, body mass index and lipoprotein composition in healthy non-diabetic men and women. Arterioscler Thromb. 12:1992;393-402.